Clinigen Group (CLIN)

 

CLIN Share PerformanceMore

52 week high904.0 30/05/17
52 week low500.0 27/06/16
52 week change 323.0 (59.21%)
4 week volume5,075,048 31/05/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Director Deals - Clinigen Group (CLIN)

Peter George, Chief Executive Officer, sold 500,000 shares in the company on the 22nd June 2017 at a price of 875.00p. The ...

Director/PDMR Shareholding

RNS Number: 0003J Clinigen Group plc 23 June 2017 23 June 2017 Director's Share Dealing Clinigen Group plc (AIM: CLIN, 'Clinigen' or the 'Group'), the global pharmaceutical and services group, announces that it was notified on 22 June 2017 that the following transactions took place on 22 June 2017. Peter George, Non-Executive Director, sold 500,000 ordinary shares...

Issue of Equity

RNS Number: 7694I Clinigen Group plc 22 June 2017 22 June 2017 Issue of Equity Clinigen Group plc (the "Group", AIM: CLIN) announces that it has made an application for the admission to trading on AIM of 1,676 ordinary shares of 0.1 pence each in the Group (the "New Ordinary Shares"), which have been issued to satisfy the exercise of share options and rank p...

Clinigen options exercised

Clinigen Group has issued 13,436 ordinary shares following the exercise of share options. At 9:34am: (LON:CLIN) Clinigen G...

Issue of Equity

RNS Number: 1508H Clinigen Group plc 07 June 2017 7 June 2017 Issue of Equity Clinigen Group plc (the "Group", AIM: CLIN) announces that it has made an application for the admission to trading on AIM of 13,436 ordinary shares of 0.1 pence each in the Group (the "New Ordinary Shares"), which have been issued to satisfy the exercise of share options and rank p...

Director/PDMR Shareholding

RNS Number: 8674G Clinigen Group plc 01 June 2017 1 June 2017 Director's Share Dealing Clinigen Group plc (AIM: CLIN, 'Clinigen' or the 'Group'), the global pharmaceutical and services group, announces that it was notified on 1 June 2017 that the following transactions took place. On 31 May, Debra Ainge, Chief Operating Officer, was granted share options of 2,839 o...

Clinigen achieves positive Cardioxane CHMP opinion

Clinigen's specialty pharma division has achieved a positive CHMP opinion in Europe to modify the current product infor...

Clinigen achieves positive Cardioxane CHMP opinion

RNS Number: 7353F Clinigen Group plc 22 May 2017 RNS Reach 22 May 2017 Clinigen achieves positive CHMP opinion concerning Cardioxane in Europe Clinigen Group plc (AIM: CLIN, 'Clinigen' or the 'Group'), the global pharmaceutical and services company, announces that its Specialty Pharma (SP) division has achieved a positive CHMP opinion in Europe to mo...

Fundamental DataMore

P/E ratio72.983
EPS11.9
Dividend yield0.461 %

Equity Research (CLIN)

Clinigen Group Plc
16/03/2017
Magnolia Petroleum (MAGP.L) 0.14p £2.45m US onshore focused oil and gas exploration and production company, announced the results of an independent Reserves Report.  The Report, which is part of the...
edison investment research
Clinigen Group Plc
01/03/2016
Edison Investment Research is terminating coverage on Clinigen Group (CLIN). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be...
edison investment research
Clinigen Group Plc
25/01/2016
Clinigen’s H116 trading statement suggests its business is performing to plan, taking into account some revenue deferrals to H2. The integration of Idis and Link, which we expect to boost its...

Latest discussion posts More

  • Re: Share Price

    Maybe it is is down to President Trump trying to remove obama care with his new healthcare bill, voting later today.
    23-Mar-2017
    bushwhacker
  • Share Price

    Can anyone comment on the decline in the share price? Appreciate any commentary.
    20-Mar-2017
    peterjg1
  • results tomorrow

    .
    14-Mar-2017
    bushwhacker

Users' HoldingsMore

Users who hold Clinigen Group also hold..
GLAXOSMITHKLINE20%
LLOYDS GRP.20%
TELFORD HOMES19%
RDS 'B'18%
BP17%

Codes & Symbols

ISINGB00B89J2419
SymbolsCLIN, LSE:CLIN, CLIN.L, CLIN:LN, LON:CLIN, XLON:CLIN